More MS news articles for April 2002

Analysis of a CD40 ligand dinucleotide microsatellite in multiple sclerosis

http://www.blackwell-synergy.com/servlet/useragent?func=synergy&synergyAction=showAbstract&doi=10.1046/j.1365-2370.2002.00270.x

European Journal of Immunogenetics
Volume 29 Issue 2 Page 81 - April 2002
Y. Dai, T. Masterman, W. Huang & J. Hillert

In recent years, numerous reports have described the diverse roles of the CD40-CD40 ligand receptor-ligand pair.

The interaction of these two cell-surface molecules regulates both humoral and cell-mediated immune functions.

Because the CD40 ligand is known to be highly expressed on the peripheral blood mononuclear cells (PBMC) of multiple sclerosis (MS) patients, and because activated helper T cells expressing CD40 ligand have been found in the brain sections of MS patients, but not in those of normal controls, the protein is believed to be involved in MS development.

We studied the influence of a polymorphic dinucleotide-repeat marker located in the 3 untranslated region of the X-linked gene encoding CD40 ligand (CD40LG) on susceptibility to and disease severity in MS.

From a total cohort of 771 Nordic definite-MS patients, the most (n = 92) and least (n = 90) disabled octiles, as well as random samples of intermediately disabled males (n = 119) and females (n = 121), were genotyped; 135 ethnically matched healthy subjects were used as controls.

In addition, the effect of the polymorphism on CD40 ligand mRNA expression was assessed using PBMC from 54 MS patients and 22 controls.

The phenotype frequencies for the CD40LG marker did not differ significantly between gender-conditioned intermediate-MS subgroups and controls, or between gender-conditioned disability octiles.

Nor did the polymorphism appear to exert any significant effect on mRNA expression in either patients or controls.
 

Copyright 2002, Blackwell Publishing Ltd